Annual Report

2018 Annual Report

OUR MISSION

The St. Baldrick's Foundation is a volunteer and donor powered charity committed to supporting the most promising research to find cures for childhood cancers and give survivors long and healthy lives.

Dear Friends,

We live in an age of accelerated scientific and technological advancement. Our rapidly expanding knowledge of the human genome, molecular biology and scores of other disciplines together with the emergence of revolutionary treatments supported by the St. Baldrick's Foundation, such as therapies that use the immune system or target specific genes to kill cancer cells, are improving the futures of children with cancer in ways unforeseen when St. Baldrick's began.

As we embark upon our 20th annual year shaving heads to support childhood cancer research, we celebrate the impact your support and leadership have made in just the last year:

The Childhood Cancer STAR Act, spearheaded by St. Baldrick's, was signed into law thanks to the help of St. Baldrick's advocates, the wider childhood cancer community and our partners in Congress. The law makes it possible to collect samples of blood, tissue, DNA, RNA and other biospecimens and data to accelerate pediatric research. It also supports studies of the incidence, distribution and control of childhood cancers to enable improved care for survivors – a critical need since a recent study funded in part by the St. Baldrick's Foundation found that by the age of 45, 99% of childhood cancer survivors will experience chronic health problems, and 96% will have had a life threatening health issue.

We cannot accept this.

Fortunately, in November 2018 the drug larotrectinib (brand name Vitrakvi) was approved - it's the first treatment developed not for a specific type of cancer, but for any cancer patient with a certain genetic fusion.

We now know cancer is less about where in the body it occurs than what biomarkers and genes are involved. Cancers that previously seemed unrelated are revealing common Achilles' heels that allow advances in one cancer to fight another. While this gives new hope to all cancer patients, it's even more vital for children since most governments, pharmaceutical companies and charities focus principally on adult cancer research.

We were honored to welcome our new partner, the Osteosarcoma Collaborative, whose commitment of $1.5 million has made possible an ambitious grant to develop new ways to treat osteosarcoma patients by targeting molecules that evade immunity. This is the first time the St. Baldrick's Foundation has issued a special call for grant applications for a particular type of childhood cancer, and we expect it to serve as a model for future collaborations with partners and major donors.

These are just a few "wins" for children and teens with cancer that you helped make possible in fiscal year 2017-2018. Advances are made daily, and with your continued support, researchers will realize even more progress in the way children with cancer are treated and saved.

Thank you for helping the St. Baldrick's Foundation take childhood back from cancer.

Michael McCreesh Profile Michael McCreesh Signature Michael McCreesh
Chairman of the Board
Father of Brent
Kathleen Ruddy Profile Kathleen Ruddy Signature Kathleen Ruddy
Chief Executive Officer
Board of Directors

Mike McCreesh, Chair
John R. Bender | Susan L. Cohn, M.D. | Tim Kenny, Treasurer | Jeffrey M. Lipton, M.D., Ph.D. | Katherine Lugar | Thomas Selquist | Kathleen Ruddy | Rebecca Chapman Weaver, Secretary (non-board member)

Board Members Emeritus

Joe Bartlett | Charles M. Chamness | Francis Feeney | Tom Leonhardt | John McKenna

Forever in Our Hearts
Robert J. Arceci, M.D., Ph.D.

Continue to Financials

Your Dollars at Work

In the Fiscal year 2017-2018, you raised $37 million.

The St. Baldrick’s Foundation remains committed to fiscal responsibility and transparency.

Every dollar we spend goes to:

  • find cures for childhood cancers — our mission
  • maximize our fundraising
  • improve the effectiveness of our organization

And of course, every dollar spent on fundraising and administration is with the goal of having more for the mission!

The expense ratios may vary each year, not only due to changing expenses, but also according to the amount raised by our volunteers.


SBF Expense Ratios SBF Expense Ratios

Look how much St. Baldrick's volunteers have raised.

Five Year Revenue Chart (In Millions)

Five Year Growth Five Year Growth


Statement of Activities

For the fiscal year ended June 30, 2018

Total Revenue, Gains and Support

$37,145,933
  • Program (childhood cancer research grants, advocacy) $27,481,920
  • Fundraising (website, T-shirts, posters, credit card processing fees, etc.) $9,332,656
  • Management and general (human resources, accounting, audit fees, etc.) $1,708,028
Total Functional Expenses
$38,522,604
  • Change in net assets ($1,376,671)
  • Net assets, beginning of year $15,395,155
  • Net assets, end of year $14,018,484

An independent audit of the St. Baldrick's Foundation has been performed by Armanino, LLP. A copy of the full financial statements is available at StBaldricks.org/financials. We will also gladly send a copy by mail upon request. Please contact Anja Kloch at 626.792.8247, ext. 268 or Anja.Kloch@StBaldricks.org. All funds reflected on this page are listed in U.S. dollars.

Champions for Change

National Partner

Signature Partners

Continue to Accomplishments

Accomplishments You Made Possible

With your support, this has been another year of making great strides toward the St. Baldrick's mission. Our research grants and advocacy efforts focus on finding better cures so kids diagnosed with cancer can live long, healthy lives.


    New funds committed July 2017 through June 2018

  • Cooperative Research (Children's Oncology Group):

    1 grant: $6,439,837

  • Consortium Research Grants:

    6 new grants to continuing Consortia: $2,352,737

  • Research Grants:

    26 grants: $2,587,744

  • Supportive Care Research Grants:

    4 grants: $199,858

  • St. Baldrick's Summer Fellows:

    19 grants: $95,000

  • St. Baldrick's Fellows:

    7 grants: $1,293,822

    7 new awards for continuing Fellows: $679,656

  • St. Baldrick's Scholars:

    11 grants: $3,491,584

    17 new awards for continuing Scholars: $1,773,240

  • St. Baldrick's International Scholars:

    2 grants: $660,000

    3 new awards for continuing International Scholars: $345,000

  • Infrastructure Grants:

    39 grants: $2,258,867

  • International Beneficiaries and Domestic Partners:

    12 grants: $599,900

  • St. Baldrick's Foundation Robert J. Arceci Innovation Award:

    1 grant: $750,000

  • St. Baldrick's Foundation Robert J. Arceci International Innovation Award:

    1 grant: $750,000

    2 new awards for continuing Innovators: $300,000

  • St. Baldrick's Foundation Innovation Award:

    3 grants: $450,000


In Case You Missed It

Mission Highlights

BIG NEWS: FDA Approves Groundbreaking CAR T Cell Therapy for Kids with Leukemia

"The FDA has approved today a transformative therapy for children with refractory leukemia. It represents the first in an entirely new class of cancer therapies that holds promise for all cancer patients. The support of the St. Baldrick's Foundation during the development of this therapy was indispensable for teaching physicians how to render it as effectively and safely as possible." Dr. Crystal L. Mackall, Professor of Pediatrics and Internal Medicine at Stanford University, associate director of Stanford Cancer Institute, and co-leader of the Stand Up to Cancer – St. Baldrick's Pediatric Dream Team.

The Childhood Cancer STAR Act Passes and is Signed Into Law

Because of your support for St. Baldrick's advocacy efforts, the Childhood Cancer STAR Act, the most comprehensive childhood cancer legislation, was passed into law in 2018. The STAR Act will help kids with cancer and childhood cancer survivors live long, healthy lives. Federal dollars for cancer research have increased this year and we are seeing the impact of increased focus and investment in pediatric cancer research because of your advocacy efforts.

An Injection of Hope: Researcher Studies Innovate Potential Therapy for DIPG

For kids diagnosed with a rare and fatal type of brain tumor called DIPG, or diffuse intrinsic pontine glioma, there is no cure and treatments are heartbreakingly scarce. St. Baldrick’s researcher Dr. Mark Souweidane is on a mission to change the bleak statistics on DIPG survival. Learn about his groundbreaking work so far and what’s coming next.

Dream Team Discovers Potential New Weapon Against Neuroblastoma

Researchers at The Children’s Hospital of Philadelphia, who are part of the Stand Up to Cancer – St. Baldrick’s Pediatric Cancer Dream Team, have found a protein, called GPC2, that appears on neuroblastoma cells and not on healthy cells. Not only that – this same protein is also necessary for neuroblastoma cells to grow. Dream Team members at the National Cancer Institute (NCI) then developed an immunotherapy weapon to hit that target. So far, in tests in the laboratory, it’s working.

This New Tool Could Mean Better Health for Childhood Cancer Survivors

St. Baldrick’s Fellow Dr. Nickhill Bhakta works at his desk in St. Jude Children’s Research Hospital. With a portion of the grant supported by the St. Baldrick’s Morgan and Friends Fund, he developed a special statistical tool to help capture the true volume and complexity of chronic health conditions faced by childhood cancer survivors because of the long-term consequences of their treatment — something that hadn’t been done before.

AML and St. Baldrick's: A Continuing Story of Progress

Through collaboration with thought leaders in the research community, St. Baldrick’s has been highly responsive to the evolving landscape of childhood AML research. Our grants support every phase of the process, including early-stage research to challenge the status-quo and drive innovation.

Continue to Our Community

Because of You

Whether you've shaved your head, donated, volunteered, organized a head shaving event or gala to raise crucial funds or advocated on Capitol Hill, St. Baldrick's couldn't do it without you — over 36,710 people shaved their head at 1,108 events. And, with over 410,500 donors we raised over $37 million to support the best childhood cancer research.

And for that, we are so very grateful!

Because of your support for St. Baldrick's advocacy efforts, the Childhood Cancer STAR Act, the most comprehensive childhood cancer legislation, was passed into law in 2018. The STAR Act will help kids with cancer and childhood cancer survivors live long, healthy lives. Federal dollars for cancer research have increased this year and we are seeing the impact of increased focus and investment in pediatric cancer research because of your advocacy efforts.


Partnerships Amplify Research Dollars

The St. Baldrick’s Foundation invites like-minded charities to fund or co-fund research projects approved through our highly respected scientific review process. This results in more efficient use of resources for grant applicants, scientific reviewers, and partnering foundations by avoiding duplication of efforts. Funding partners enable more highly impactful research to be funded, and by joining forces, we stand stronger as champions for childhood cancer research. Below is our list of current partners.


Griffin’s Guardians

Griffin's Guardians

Griffin's Guardians was created by Erin and Adam Engle in memory of their son, Griffin, who fought a courageous battle with Glioblastoma Multiform, an aggressive form of brain cancer, at the age of seven. Griffin's Guardians' mission is to continue the fight for Griffin by providing support and financial assistance to children battling cancer in Central New York, to bring awareness and to provide funding for pediatric cancer research.

Love Your Melon

Love Your Melon

Love Your Melon is an apparel brand dedicated to giving a hat to every child battling cancer in America as well as supporting nonprofit organizations who lead the fight against pediatric cancer.

Making Headway Foundation

Making Headway Foundation

For over 20 years, the Making Headway Foundation’s mission has been to provide care and comfort for children with brain and spinal cord tumors while funding medical research geared to better treatments and a cure. Making Headway offers a continuum of services that includes individual counseling, educational advocacy, in-hospital quality-of-life programs, scholarships, fun family events, medical research grants, facilitating clinical trials, neuro-oncology fellowships, and so much more.

McKenna Claire Foundation

McKenna Claire Foundation

The McKenna Claire Foundation was conceived after Kristine and Dave Wetzel lost their youngest daughter, McKenna, to Diffuse Intrinsic Pontine Glioma (DIPG) two weeks shy of her 8th birthday. The mission of the McKenna Claire Foundation is to cure pediatric brain cancer by raising awareness, increasing community involvement and funding research.

Micaela's Army Foundation

Micaela's Army Foundation

Originally, Micaela’s Army was a group of prayer warriors who loved and supported Micaela throughout her battle with AML. Now, Micaela’s spirit inspires the fight to find a cure for childhood, adolescent, and young adult cancers. The mission of Micaela’s Army is to raise and donate money to help fund cancer research, education, awareness, and patient support for the cancers that affect children and their families.

Osteosarcoma Collaborative

Osteosarcoma Collaborative

The Osteosarcoma Collaborative’s mission is to bring together data, researchers, patients and families to find new cures for osteosarcoma. Through advocacy, fundraising, education and awareness regarding the disease, it supports new treatment options for patients with this extremely aggressive and often recurring disease. In partnership with St. Baldrick’s, the Osteosarcoma Collaborative is funding research to develop new ways to treat osteosarcoma patients using immunotherapies.

Paint the Town Gold

Painting the Town Gold

Established by 17-year-old Todd Schultz of Glen Carbon, IL who is in treatment for high risk Philadelphia chromosome positive acute lymphoblastic leukemia, Painting the Town Gold helps communities take up the fight against childhood cancers throughout September by hosting a wide variety of fundraisers. Painting the Town Gold focuses on providing research funding for all types of childhood cancer.

Team Campbell Foundation

Team Campbell Foundation

Team Campbell Foundation aims to improve the lives of those fighting childhood cancer by raising awareness, funding research and providing psycho-social enrichment opportunities. By partnering with St. Baldrick’s, the foundation helps to fund the critical research necessary to find a cure for childhood cancer.

The V Foundation for Cancer Research

The V Foundation for Cancer Research

The V Foundation for Cancer Research is a charitable organization dedicated to saving lives by helping to find a cure for cancer. The Foundation seeks to make a difference by generating broad-based support for cancer research and by creating an urgent awareness among all Americans of the importance of the war against cancer. The Foundation performs these dual roles through advocacy, education, fundraising, and philanthropy.

TLC Foundation

TLC Foundation

The Ty Louis Campbell (TLC) Foundation was created in memory of Ty, who lost his 2-year battle with brain cancer just days after his fifth birthday. The TLC Foundation funds innovative research and clinical trials specifically geared toward the treatment of the deadliest childhood cancers (including brain and spinal cord tumors). TLC seeks less toxic, more effective treatments that are specifically designed for children fighting cancer. The ultimate mission is to help fund the intelligence and technology that will uncover new ways to cure children with cancer.

Tough Like Ike

Tough Like Ike

Created in honor of Ike Yarmon who was diagnosed with acute lymphoblastic leukemia when he was four and is now in remission. Throughout his battle, Ike was resilient and inspired the family motto "tough like Ike". The foundation seeks to raise awareness and funds for research of leukemia and other childhood cancers in order to find new cures.

Continue to Hero Funds

We are grateful to the 2018 Ambassadors and their families for sharing their achievements and challenges. Their courage, commitment and strength are an inspiration.


Hero Funds

In the 2017-2018 fiscal year, Hero Funds raised over $2.9 million.

Hero Funds offer families an opportunity to join forces with St. Baldrick’s to fund the world’s best childhood cancer research while honoring a loved one. Families have access to our exceptional fundraising tools and highly-respected grantmaking program. Because of this support, each Hero Fund can cast a wider fundraising net to raise much needed dollars for childhood cancer research. Our sincere thanks to the following Hero Funds that were active during the fiscal year ending June 30, 2018.

Thank You

For an Amazing Year

You can be part of the next research breakthrough for kids with cancer. Donate today.